SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as Novo Nordisk's lawsuit and increased regulatory scrutiny over its compounded GLP-1 weight-loss medications have led the company to halt sales of its unapproved pill; this has polarized community sentiment, with bulls anticipating a bounce and bears predicting further declines due to legal risks.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as Morgan Stanley initiated 'Overweight' coverage with a $37 price target, citing its strong power infrastructure and strategic pivot towards AI/HPC data center conversions. The community is anticipating continued growth and potential for a significant short squeeze, fueled by institutional confidence and its key partnership with Google.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amidst intense community discussion driven by Tether's substantial investments and multi-year spending commitments, coupled with the transformative Northern Data acquisition positioning it as a significant AI and cloud infrastructure player. This robust backing, alongside the launch of Rumble Shorts and Wallet and the return of key content creators, is fueling widespread speculation about a massive short squeeze given historically high short interest.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending following its Q4 earnings report, which highlighted a revenue miss but an adjusted EPS beat, alongside management's optimistic outlook for 2026, spurred by an improved trade environment and the end of a low-margin slab contract. Community sentiment is mixed, with some investors frustrated by ongoing losses, while others see a buying opportunity driven by potential short covering and ongoing strategic partnership talks with POSCO.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies ($PGY) is trending amidst sharp post-earnings volatility, as a slight revenue miss and cautious guidance overshadow its continued profitability and new forward flow agreement, driving a fierce debate among investors who see an extreme overreaction and a significant buying opportunity against those concerned about broader fintech weakness and ongoing share price manipulation.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean ($RIG) is trending after announcing a $5.8 billion all-stock acquisition of Valaris ($VAL), aiming to create an offshore drilling industry leader positioned for an emerging upcycle. While some investors anticipate significant synergies and long-term benefits from the combined fleet, community discussion highlights concerns about the all-stock deal's implications for RIG's debt and share valuation, with Valaris shareholders initially seeing more immediate gains.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl is experiencing an extreme sell-off and trading halts after cutting its earnings outlook and announcing leadership changes including its CFO and general counsel amid a financial reporting review, fueling community speculation around financial improprieties. While many fear further declines, other investors are actively discussing the steep drop as an overreaction and a potential 'buy the dip' opportunity for the IT services firm.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending following its approximately $35 million cash-and-stock acquisition of AI vision specialist StereoLabs, which unifies lidar and camera platforms for Physical AI. The market and community are largely optimistic, highlighting StereoLabs' profitability and expanded customer base as a strategic move solidifying Ouster's leadership in robotics and smart infrastructure, despite some minor concerns about valuation.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum (LITE) is experiencing significant momentum after reporting strong earnings and an optimistic outlook, driven by its critical role in the AI-fueled optical supercycle and increasing demand for co-packaged optics (CPO) and optical circuit switches (OCS), though some investors caution about its rapid valuation climb.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is trending sharply lower following its Q4 earnings, where a beat on top and bottom lines was overshadowed by soft revenue guidance for the upcoming quarter and full year, fueling intense community debate on whether the sell-off is an overreaction or signals deeper challenges amid broader AI-driven software sector revaluations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of "Hold" from Analysts

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) have been given a consensus rating of "Hold" by the nine brokerages that are currently covering the stock, Marketbeat reports. Two...

Sutro Biopharma (STRO) Soars 5.9%: Is Further Upside Left in the Stock?

Sutro Biopharma (STRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Sutro Biopharma (NASDAQ:STRO) Raised to "Market Outperform" at Citizens Jmp

Citizens Jmp upgraded Sutro Biopharma from a "market perform" rating to a "market outperform" rating and set a $23.00 price objective for the company in a research note on Tuesday...

Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 27.8% in December

Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) was the recipient of a significant decline in short interest in December. As of December 31st, there was short interest totaling 404,777 shares...

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of "Hold" by Analysts

Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) has been given a consensus recommendation of "Hold" by the eight analysts that are presently covering the stock, MarketBeat.com reports. Two...

FY2025 EPS Estimate for Sutro Biopharma Increased by Analyst

Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) - Investment analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for Sutro Biopharma in a report issued on Monday...

Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 85.9% in December

Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totaling...

HC Wainwright Forecasts Strong Price Appreciation for Sutro Biopharma (NASDAQ:STRO) Stock

HC Wainwright increased their target price on shares of Sutro Biopharma from $2.00 to $10.00 and gave the stock a "neutral" rating in a research report on Monday...

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines PR Newswire...

Velan Capital Investment Management LP Acquires 2,030,000 Shares of Sutro Biopharma, Inc. $STRO

Velan Capital Investment Management LP lifted its stake in Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) by 197.1% during the second quarter, according to the company in its most recent 13F...

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Sutro Biopharma Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Current Price	$14.26
Prev Close	$15.52
Open	$15.15
Dividend Yield	0.00%
50-Day Moving Average	$11.70
Beta	1.48
Avg. Volume	126,127.95
PE Ratio	-0.60

52-Week High	$20.20
52-Week Low	$5.23
Market Capitalization	$132.22M
EPS (Annual)	-$29.61
Price to Book	-1.51
Revenue Per Employee	$183,559.17

STRO
Sutro Biopharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest STRO News

STROSutro Biopharma Inc